Can I Take Creatine with Wegovy? A Clinical Review

What Wegovy Does That Touches This Question

Wegovy injection is a once-weekly subcutaneous GLP-1 receptor agonist. In STEP 1, 1,961 adults without diabetes lost a mean 14.9% of body weight at 68 weeks on semaglutide 2.4 mg versus 2.4% on placebo [8].

Two label effects matter for anyone adding creatine. The first is kidney monitoring. The Wegovy label warns about acute kidney injury from volume depletion, reported at 0.4 versus 0.2 cases per 100 patient-years (7 versus 4 adults), more often in people with existing renal impairment and during dose escalation, and often after gastrointestinal fluid loss. It says to monitor renal function in patients reporting reactions that could lead to volume depletion [1]. Creatine use matters when those tests include serum creatinine or creatinine-based eGFR [1][2][3].

The second is gastric emptying. Semaglutide delays gastric emptying, and the label says the drug is not recommended in patients with severe gastroparesis [1].

Is There a Pharmacokinetic Interaction?

The Wegovy label does not describe one. Semaglutide is broken down by proteolytic cleavage of its peptide backbone and beta-oxidation of its fatty acid side chain rather than by cytochrome P450 enzymes [1]. Creatine is a supplement, not an approved drug: the body makes about 1 g/day from glycine, arginine and methionine, it is eaten in meat and fish, and it is sold over the counter. A Drugs@FDA search returns no approved drug application with creatine as the active ingredient [4][9].

The Wegovy label's interaction section covers two things: insulin and insulin secretagogues such as sulfonylureas, because of hypoglycemia risk, and oral medicines whose absorption may change because gastric emptying is slower, with closer monitoring advised for narrow therapeutic index drugs [1]. The label does not name creatine in that section [1].

Creatine Can Make Kidney Blood Tests Harder to Interpret

Wegovy carries its own separate warning about acute kidney injury after fluid loss from gastrointestinal reactions [1]. Creatine raises a different issue: it can make kidney blood tests harder to interpret [2][3].

The body turns creatine into creatinine, and standard kidney panels measure creatinine. Two pooled analyses put a number on it:

• 19 randomized trials plus one crossover study: serum creatinine up 0.13 mg/dL (95% CI 0.07 to 0.18), with no difference in urea and no difference in eGFR (mean difference -5.20 mL/min/1.73 m2, 95% CI -15.00 to 4.60). Subgroups under and over one month of supplementation did not differ for serum creatinine, urea or eGFR [2].
• 26 studies with 1,036 people: serum creatinine up 0.14 mg/dL (95% CI 0.05 to 0.22). Creatinine-based GFR fell by 10.75 mL/min (95% CI -17.48 to -4.02), but GFR measured by Cr-EDTA clearance did not change (+5.89 mL/min, 95% CI -0.30 to 12.08), and urea, albuminuria and proteinuria were unchanged [3].

That split is the point. A creatinine-based eGFR can under-read kidney function in someone taking creatine. The authors of the 26-study analysis read the pattern as altered creatinine metabolism rather than kidney injury [3]. Anyone ordering kidney tests should know about creatine use.

Do the Direct Filtration Measurements Show Harm?

Where filtration was measured by a method that does not depend on creatinine, it held up.

• Resistance-trained adults eating at least 1.2 g of protein per kg per day took 20 g/day of creatine for 5 days then 5 g/day for 12 weeks: 51Cr-EDTA clearance was 101.4 to 108.8 mL/min/1.73 m2 on creatine versus 103.3 to 106.7 on placebo (group-by-time p=0.64) [5].
• Adults with type 2 diabetes, 12 weeks with exercise: 51Cr-EDTA clearance was 90.4 to 96.1 on creatine versus 97.9 to 96.4 on placebo (p=0.58), with proteinuria and albuminuria unchanged [6].
• 18 sedentary men taking about 10 g/day for 3 months with aerobic training: cystatin C, a marker not made from creatine, fell from 0.82 to 0.71 mg/L on creatine versus 0.88 to 0.75 on placebo [7].
• 98 college football players followed for up to 21 months on about 5 g/day after a loading phase showed no significant group differences on a broad blood and urine panel that included renal markers. This study was open label [10].

The counterweight is a single case report: a 24-year-old weightlifter developed acute renal failure with biopsy-proven acute interstitial nephritis while taking creatine plus several other supplements, and recovered fully after stopping all of them. Creatine cannot be singled out from that case [11].

People with kidney disease are a different group. Few trials enrolled them: the type 2 diabetes trial above, and a hemodialysis subgroup in the 26-study analysis in which serum creatinine rose and urea fell. Long-term safety in advanced kidney disease is not established by these data [3][6].

Dosing, and Whether to Load

NIH ODS describes the protocols used in studies: 20 g/day of creatine monohydrate in four 5 g portions for 5 to 7 days followed by 3 to 5 g/day, or about 3 to 6 g/day for 3 to 4 weeks with no loading phase. These are study protocols, not prescriptions [4].

Without a loading phase, muscle creatine fills more slowly. In one study of 31 men, 3 g/day for 28 days produced roughly the same 20% rise in muscle total creatine as 20 g/day for 6 days, just more gradually [12].

The International Society of Sports Nutrition position stand states that short- and long-term supplementation, up to 30 g/day for 5 years, is safe and well tolerated in healthy people and some patient groups ranging from infants to the elderly. That is a society position paper, not a regulator's finding [13].

Water Weight, the Scale, and Wegovy's Own Weight Loss

The one consistent side effect in NIH ODS's review is weight gain from water retention, about 1 to 2 kg in a month alongside strength training. Anecdotal reports include nausea, diarrhea, muscle cramps and heat intolerance, and adequate hydration may minimize them [4]. A 1 to 2 kg rise on the scale in the first month of creatine can therefore reflect water retention rather than fat.

Dehydration and heat have been tested directly. Twelve active men took 21.6 g/day for 7 days, lost 2% of body mass, then completed an 80-minute heat tolerance test at 33.5 C. Body mass rose 0.88 kg on creatine, but rectal temperature (39.3 versus 39.4 C) and the other thermoregulatory and cardiorespiratory responses did not differ from placebo [14].

Does Creatine Protect Muscle During Wegovy Weight Loss?

No controlled human study has tested whether creatine preserves lean mass during semaglutide-related weight loss. Creatine combined with resistance training has improved lean tissue mass and strength in older adults [15][16].

What is established is narrower. NIH ODS describes creatine as best supported for repeated short bursts of high-intensity effort such as sprinting and weight training, of little value for endurance sports, where its weight gain may hurt performance [4].

What the Wegovy Label Says to Watch For

Most of the label's cautions are not about supplements. Hypoglycemia risk rises when Wegovy is combined with insulin or a sulfonylurea: glucose below 54 mg/dL occurred in 6.2% on Wegovy 2.4 mg versus 2.5% on placebo in adults with type 2 diabetes and a BMI of 27 or higher, and the risk was higher with a sulfonylurea [1]. The kidney warning described earlier is the other one.

Gastrointestinal reactions are the most common adverse effects and the setting in which the kidney warning sits: nausea 44% versus 16%, diarrhea 30% versus 16%, vomiting 24% versus 6% and constipation 24% versus 11% in pooled trials of Wegovy 2.4 mg [1]. The label says to monitor renal function in patients reporting reactions that could lead to volume depletion [1].